Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × Eflornithine × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Adenomatous Polyposis Coli 2 Urinary Bladder Neoplasms 1 Precancerous Conditions 1 Glioma 1 Colorectal Neoplasms 1 Colonic Polyps 1 Carcinoma, Basal Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Fluorouracil 131 Leucovorin 127 Oxaliplatin 93 Bevacizumab 85 Irinotecan 74 Capecitabine 63 Cetuximab 46 Folfox protocol 32 Panitumumab 18 regorafenib 16 trifluridine tipiracil drug combination 15 Drug Therapy 14 Chemotherapy, Adjuvant 13 IFL protocol 10 Floxuridine 10 Radiotherapy 9 Tegafur 7 Neoadjuvant Therapy 7 Levoleucovorin 7 Laparoscopy 7 Aspirin 7 pembrolizumab 6 Celecoxib 6 atezolizumab 5 XELOX 5 Trifluridine 5 Mitomycin 5 Colonoscopy 5 sintilimab 4 dehydroftorafur 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01349881 2026-04-02

PACES

SWOG Cancer Research Network

Phase 3 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡